Antonino Bagnulo

Dr. Antonino Bagnulo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Federico IacovelliFederico Iacovelli
Federico Iacovelli
gaetana Costanzagaetana Costanza
gaetana Costanza
Alice RomeoAlice Romeo
Alice Romeo
Terenzio CosioTerenzio Cosio
Terenzio Cosio
CLCaterina Lanna
Caterina Lanna
Elena CampioneElena Campione
Elena Campione
(1) Background: Pelargonium sidoides extracts and lactoferrin are two important natural, anti-inflammatory, and antiviral agents, which can interfere with the early stages of SARS-CoV-2 infection. Molecular docking and molecular dynamics simulation approaches have been applied to check for the occurrence of interactions of the Pelargonium sidoides compounds with lactoferrin and with SARS-CoV-2 components. (2) Methods: Computational methods have been applied to confirm the hypothesis of a direct interaction between PEL compounds and the lactoferrin protein and between Pelargonium sidoides compounds and SARS-CoV-2 Spike, 3CLPro, RdRp proteins, and membrane. Selected high-score complexes were structurally investigated through classical molecular dynamics simulation, while the interaction energies were evaluated using the molecular mechanics energies combined with generalized Born and surface area continuum solvation method. (3) Results: Computational analyses suggested that Pelargonium sidoides extracts can interact with lactoferrin without altering its structural and dynamical properties. Furthermore, Pelargonium sidoides compounds should have the ability to interfere with the Spike glycoprotein, the 3CLPro, and the lipid membrane, probably affecting the functional properties of the proteins inserted in the double layer. (4) Conclusion: Our findings suggest that Pelargonium sidoides may interfere with the mechanism of infection of SARS-CoV-2, especially in the early stages.

21 September 2021 in Life
Verified
Journal Article
Open access
PDF file
Raffaella BelvedereRaffaella Belvedere
Raffaella Belvedere
NNNunzia Novizio
Nunzia Novizio
Daniela ElettoDaniela Eletto
Daniela Eletto
Amalia PortaAmalia Porta
Amalia Porta
ABAntonino Bagnulo
Antonino Bagnulo
APAntonello Petrella
Antonello Petrella
Epistaxis is one of the most frequent hemorrhages resulting from local or systemic factors. Its management without hospitalization has prompted an interest in locally applied hemostatic agents. Generally, the therapy approaches involve sprays or creams acting as a physical barrier, even used as tampons or gauze. In this study, we have investigated the activity of Emoxilane®, a combination of sodium hyaluronate, silver salt, α-tocopherol acetate and D-panthenol, which is known to be able to separately act in a different biological manner. Our in vitro results, obtained on endothelial and nasal epithelial cells, have shown that the association of these molecules presented a notable antioxidant activity mainly due to the α-tocopherol and D-panthenol and a significant antimicrobial role thanks to the silver compound. Moreover, remarkable hemostatic activity was found by evaluating plasmin inhibition attributable to the sodium hyaluronate. Interestingly, on human plasma, we have confirmed that Emoxilane® strongly induced the increase of thrombin levels. These data suggest that the use of this association could represent an appealing pharmacological approach to actively induce hemostasis during epistaxis. Our future perspective will aim to the creation of a formulation for an easy topical application in the nose which is able to contrast the bleeding.

1 November 2023 in Gazzetta Medica Italiana Archivio per le Scienze Mediche
Verified
Journal Article
Closed access
ABAntonino Bagnulo
Antonino Bagnulo
UMUmberto DI Maio
Umberto DI Maio
VPVincenzo Piscitelli
Vincenzo Piscitelli
TVTatjana Volpicelli
Tatjana Volpicelli
Article: Miraferrum® forte: a new promising food supplement in gynecological disorders based on iron deficiency - Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2023 September;182(9):497-501 - Minerva Medica - Journals

18 February 2024 in Gastrointestinal Disorders
Verified
Journal Article
Open access
PDF file
MMMarisa Francesca Motta
Marisa Francesca Motta
GPGiuseppe Pulitano
Giuseppe Pulitano
ABAntonino Bagnulo
Antonino Bagnulo
GBGiampaolo Buriani
Giampaolo Buriani
UMUmberto Di Maio
Umberto Di Maio
RMRocco Malivindi
Rocco Malivindi
TAMIXAM® is a novel technology that combines hyaluronic acid and tamarind seed extract in its formulation. It is designed to protect the esophageal mucosa by creating a barrier through its filmogenic properties. The aim of this study is to evaluate the safety and efficacy of this technology through mucoadhesion tests, a cell viability assay, TEER measurements, and morphological analysis on reconstructed esophageal mucosa exposed to 10% hydrochloric acid before and after treatment. The mucoadhesion test highlighted the synergistic bioadhesive effect of the technology’s components. Cell viability assays revealed the substantial mucoprotective and barrier effects of the technology, preserving tissue viability when applied before exposure to acid insult. A morphological analysis illustrated TAMIXAM®’s efficacy in countering acid-induced damage, reducing erosion, necrosis, and tissue degeneration compared to the positive control, both pre- and post-acid insult. An evaluation of epithelial integrity through TEER measurements indicated a minimal reduction in tissues treated with the invention before acid exposure, demonstrating its ability to maintain epithelial integrity in the presence of an acid insult. However, this effect was less pronounced in tissues treated with the technology after the acid insult, implying a potential partial recovery of epithelial integrity. Furthermore, comprehensive in vitro and in vivo studies supported the safety profile of the invention. In conclusion, TAMIXAM® emerged as a compelling solution, providing enhanced mechanical action to maintain epithelial balance and shield the esophageal mucosa from acid-induced damage.

19 January 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PCPaola De Cicco
Paola De Cicco
Nunzio Antonio CacciolaNunzio Antonio Cacciola
Nunzio Antonio Cacciola
RARebecca Amico
Rebecca Amico
BRBarbara Romano
Barbara Romano
UMUmberto Di Maio
Umberto Di Maio
Francesca BorrelliFrancesca Borrelli
Francesca Borrelli
Background/Objectives: Gastro-oesophageal reflux disease (GERD) refers to a disease in which stomach acid rises into the oesophagus. Currently, proton pump inhibitors (PPIs) are the most commonly used medications to treat GERD. However, long-term use of PPIs is not free from side effects, and new treatment strategies are needed. The present study was conducted to evaluate the gastroprotective potential of four different formulations containing both antiacids and medicinal plants considered useful for the treatment of GERD. Methods: The protective effects of the formulations on gastric ulcers in pyloric ligation-induced gastric mucosal lesions in mice were evaluated by measuring gastric emptying, the ulcer index, gastric content, total acidity, and the pH of the gastric fluid. Gastric damage was also assessed by measuring myeloperoxidase (MPO) activity. Results: Formulations containing Glycyrrhiza glabra L. or Glycyrrhiza glabra L. plus Opuntia ficus-indica Mill. and Olea europaea L. (formulations 3 and 4, respectively) increased gastric emptying. All formulations decreased gastro-oesophageal damage (ulceration and MPO activity) and gastric contents and had no effects on total acidity or gastric fluid pH in the pyloric ligation ulcer model. Conclusions: Our results show that all formulations are able to exert cytoprotective and anti-ulcerative effects. However, among the formulations, formulation 4 seems to be the most promising because of its better effects on gastric injury and gastric emptying. These results support the hypothesis of the possible use of medicinal plants in combination with antacid agents in the treatment of GERD.